Clinical Trials for Amyotrophic Lateral Sclerosis (ALS)
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Meet a team of experts who focus on you and your condition. Visit the clinic to make an appointment.
Amyotrophic Lateral Sclerosis (ALS)
Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative disease. The brain's loss in muscle control results in paralysis.
Amyotrophic Lateral Sclerosis ALS lou-gehrig's-disease rarely charcot disease ALS treatment